A Double-blind, Randomized, Placebo- and Active-Controlled Study of F2695 SR in Adult Patients With Fatigue Associated With Major Depressive Disorder.
Phase of Trial: Phase II
Latest Information Update: 02 Oct 2014
At a glance
- Drugs Levomilnacipran (Primary) ; Citalopram; Fluoxetine; Paroxetine; Sertraline
- Indications Fatigue; Major depressive disorder
- Focus Therapeutic Use
- 01 Aug 2012 Actual end date Jul 2012 added as reported by ClinicalTrials.gov.
- 01 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 May 2012 Planned end date changed from 1 May 2012 to 1 Jul 2012 as reported by ClinicalTrials.gov.